Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 40 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
15 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
iVascular Benelux from Mechelen, company number BE1022264291, closed financial year 2025 with a result of € -175,968 after tax. For that financial year iVascular Benelux recorded a gross margin of € 10,285 and equity of € 124,032. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
€ 124,032
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -175,968
Profit after tax over the fiscal year.
€ 312,366
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -175,968.
People and assets in 2025
0.6
Average over the fiscal year, from the social balance sheet.
€ 44,707
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3.4 million
Supplier invoices still open on the last day of the fiscal year.
€ 47,469
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to iVascular Benelux?
What happened at iVascular Benelux in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Luis Duocastella Codina stepped down as director. NBB
- Jan Van Overbeke stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 175,968. Source: NBB ↗
- New establishment in Mechelen. KBO
- Luis Duocastella Codina became a director. NBB
- Jan Van Overbeke became a director. NBB
- Start of the company according to the CBE. KBO
In short
Paid € 87 in corporate taxes since 2025.
A new publication or filing at iVascular Benelux? We notify you, reason included.
Follow iVascular BeneluxDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Life Vascular Devices Biotech, SL Group (100%).
Directors
According to the 2025 annual accounts
Luis Duocastella Codina
Director
since 2025 · until 2028
Jan Van Overbeke
Director
since 2025 · until 2028
Shareholders
Life Vascular Devices Biotech, SL Group
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Motstraat 30
2800 Mechelen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 15 companies are registered at this address.
All companies at this address →WOLTERS KLUWER BELGIUM
€ 169.8 million revenue · 2025
FIRST-CONNECT
€ -410 gross margin · 2024
NCOI
€ 10.1 million revenue · 2025
Wolters Kluwer TAA Europe
ELIMITY
€ 215,124 gross margin · 2025
+10 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1022.264.291
- VAT number
- BE 1022.264.291
- Registered office
- Motstraat 30, 2800 Mechelen
- Names & denominations
- iVascular Benelux
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 April 2025
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Verhuur en lease van medisch en paramedisch materieel
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden